A pilot study concerning the early immunosuppressive effects of rifampin in man.
D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D001435:Bacteriophages; D004267:DNA Viruses; D006659:Histoplasmin; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents; D007538:Isoniazid / Q000627:therapeutic use; D008875:Middle Aged; D003904:Mitosporic Fungi / Q000276:immunology; D009109:Mumps virus / Q000276:immunology; D009500:Neutralization Tests; D010865:Pilot Projects; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D012882:Skin Tests; D013997:Time Factors; D014249:Trichophyton; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D006659:Histoplasmin; D007538:Isoniazid; D012293:Rifampin